Atlas Trials

A Study Investigating the Distribution and Metabolism of Three 14C-labeled Radioactive Study Compounds

Clinical trial NCT04676906 · COMPLETED

Trial details

NCT number
NCT04676906
Sponsor
Novo Nordisk A/S
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy VolunteersType 2 Diabetes
Start date
2020-11-26
Primary completion
2021-04-28
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.